Nephropathy

Glucose time in range and peripheral neuropathy in type 2 diabetes mellitus and chronic kidney disease
Laura Mayeda, Ronit Katz, Iram Ahmad, Nisha Bansal, Zona Batacchi, Irl B Hirsch, Nicole Robinson, Dace L Trence, Leila Zelnick, Ian H de Boer

BMJ Open Diabetes Research and Care Jan 2020, 8 (1) e000991; DOI: 10.1136/bmjdrc-2019-000991
Association of the IgG N-glycome with the course of kidney function in type 2 diabetes
Sunny S Singh, Ralph Heijmans, Claudia K E Meulen, Aloysius G Lieverse, Olga Gornik, Eric J G Sijbrands, Gordan Lauc, Mandy van Hoek

BMJ Open Diabetes Research and Care Apr 2020, 8 (1) e001026; DOI: 10.1136/bmjdrc-2019-001026
Clinicopathological features of fast eGFR decliners among patients with diabetic nephropathy
Kengo Furuichi, Miho Shimizu, Masayuki Yamanouchi, Junichi Hoshino, Norihiko Sakai, Yasunori Iwata, Tadashi Toyama, Shinji Kitajima, Akinori Hara, Yukio Yuzawa, Hiroshi Kitamura, Yoshiki Suzuki, Hiroshi Sato, Noriko Uesugi, Yoshihiko Ueda, Shinichi Nishi, Tomoya Nishino, Kenichi Samejima, Kentaro Kohagura, Yugo Shibagaki, Hirofumi Makino, Seiichi Matsuo, Yoshifumi Ubara, Hitoshi Yokoyama, Takashi Wada

BMJ Open Diabetes Research and Care Jun 2020, 8 (1) e001157; DOI: 10.1136/bmjdrc-2019-001157
Systemic AAV10.COMP-Ang1 rescues renal glomeruli and pancreatic islets in type 2 diabetic mice
Mi Tian, Lara S Carroll, Li Tang, Hironori Uehara, Christof Westenfelder, Balamurali K Ambati, Yufeng Huang

BMJ Open Diabetes Research and Care Aug 2020, 8 (1) e000882; DOI: 10.1136/bmjdrc-2019-000882
Declining trends of diabetic nephropathy, retinopathy and neuropathy with improving diabetes care indicators in Japanese patients with type 2 and type 1 diabetes (JDDM 46)
Hiroki Yokoyama, Shin-ichi Araki, Koichi Kawai, Katsuya Yamazaki, Osamu Tomonaga, Shin-ichiro Shirabe, Hiroshi Maegawa

BMJ Open Diabetes Research and Care May 2018, 6 (1) e000521; DOI: 10.1136/bmjdrc-2018-000521
Anagliptin ameliorates albuminuria and urinary liver-type fatty acid-binding protein excretion in patients with type 2 diabetes with nephropathy in a glucose-lowering-independent manner
Munehiro Kitada, Shin-ichi Tsuda, Kazunori Konishi, Ai Takeda-Watanabe, Mizue Fujii, Keizo Kanasaki, Makoto Nishizawa, Atsushi Nakagawa, Daisuke Koya

BMJ Open Diabetes Research and Care Jul 2017, 5 (1) e000391; DOI: 10.1136/bmjdrc-2017-000391
Linagliptin monotherapy compared with voglibose monotherapy in patients with type 2 diabetes undergoing hemodialysis: a 12-week randomized trial
Katsuhito Mori, Masanori Emoto, Tetsuo Shoji, Masaaki Inaba

BMJ Open Diabetes Research and Care Jul 2016, 4 (1) e000265; DOI: 10.1136/bmjdrc-2016-000265
Dipeptidyl peptidase-4 inhibition by Saxagliptin prevents inflammation and renal injury by targeting the Nlrp3/ASC inflammasome
Yochai Birnbaum, Mandeep Bajaj, Jinqiao Qian, Yumei Ye

BMJ Open Diabetes Research and Care Aug 2016, 4 (1) e000227; DOI: 10.1136/bmjdrc-2016-000227
Relationship between diabetic nephropathy and depression: a cross-sectional analysis using the Diabetes Study from the Center of Tokyo Women's Medical University (DIACET)
Keiko Takasaki, Tetsuya Babazono, Kaya Ishizawa, Junnosuke Miura, Yasuko Uchigata

BMJ Open Diabetes Research and Care Dec 2016, 4 (1) e000310; DOI: 10.1136/bmjdrc-2016-000310
Renal histological heterogeneity and functional progress in normoalbuminuric and microalbuminuric Japanese patients with type 2 diabetes
Tatsumi Moriya, Yoshiki Suzuki, Shigeki Inomata, Masayuki Iwano, Masao Kanauchi, Masakazu Haneda

BMJ Open Diabetes Research and Care Aug 2014, 2 (1) e000029; DOI: 10.1136/bmjdrc-2014-000029

Main menu

Nephropathy

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Nephropathy

Pages